AI MARKET SCANNING

$PHO.OL

🔒 Europe

Photocure ASA

🏛️ EURONEXT OSLO 📁 Health Technology 🏭 Medical Specialties
AVG HISTORICAL GAP +1.18%
MAX GAP RECORD -8.55%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $PHO.OL
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 28, 2026 Earnings Release 2026-10-28 (BEFORE OPEN)
+0.00%
Jul 29, 2026 Earnings Release 2026-07-29 (AFTER CLOSE)
-0.18%
Feb 18, 2026 Earnings Release 2026-02-18 (AFTER CLOSE)
-0.80%
Oct 29, 2025 Earnings Release 2025-10-29 (BEFORE OPEN)
+4.48%
Jul 30, 2025 Earnings Release 2025-07-30 (BEFORE OPEN)
+3.25%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+1.34%
Feb 19, 2025 Earnings Release 2025-02-19 (BEFORE OPEN)
-4.64%
Nov 13, 2024 Earnings Release 2024-11-13 (BEFORE OPEN)
-0.18%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.4%
Bullish Gaps (8)
Bearish Gaps (2)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $PHO.OL

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Photocure ASA engages in the development and commercialization of pharmaceutical products based on photodynamic technology. Its products include Metvix for nonmelanoma skin cancer, Hexvix/Cysview for better detection and management of bladder cancer, and Cevira which is a photodynamic drug-device combination product for non-surgical treatment of high-grade cervical dysplasia. The company…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗